HIF1A-AS1 promotes the gemcitabine resistance of pancreatic cancer by translationally upregulating HIF1α and facilitating the interaction of YB1 to Akt, inducing the phosphorylation of YB1 [47]. Here, AKT1 is linked to pancreatic neoplasm.